Axogen (AXGN) Research & Development (2010 - 2026)

Axogen's Research & Development history runs 17 years deep, the most recent figure standing at $7.5 million for Q1 2026.

• On a quarterly basis, Research & Development fell 64.28% year-over-year to $7.5 million in Q1 2026; TTM through Mar 2026 was -$15.7 million, a 154.17% decrease from a year earlier, with the FY2025 full-year figure at $32.9 million, up 18.43% from the prior year.
• Research & Development advanced to $7.5 million in Q1 2026 per AXGN's latest filing, from -$37.6 million in the prior quarter.
• Across five years, Research & Development topped out at $21.0 million in Q1 2025 and bottomed at -$37.6 million in Q4 2025.
• The 5-year median for Research & Development is $7.5 million (2026), against an average of $2.7 million.
• Across the five-year window, Research & Development tumbled 650.97% in 2022 and surged 213.23% in 2024, its largest moves.
• Year by year, Research & Development stood at -$34.7 million in 2022, then gained by 13.22% to -$30.1 million in 2023, then retreated by 1.79% to -$30.7 million in 2024, then slipped by 22.74% to -$37.6 million in 2025, then surged by 119.97% to $7.5 million in 2026.
• Per Business Quant, the three latest AXGN Research & Development figures stand at $7.5 million (Q1 2026), -$37.6 million (Q4 2025), and $7.6 million (Q3 2025).